Alterations of skin-associated lymphoid tissue in the carcinogenesis of arsenical skin cancer
- PMID: 1385879
Alterations of skin-associated lymphoid tissue in the carcinogenesis of arsenical skin cancer
Abstract
We investigated the skin-associated lymphoid tissue in arsenical skin cancers, including 14 Bowen's disease, 6 basal cell carcinoma and 6 squamous cell carcinoma patients from an endemic area by immunohistochemical and morphometric methods. There was a progressive decrease of Langerhans cells in the order of normal skin, normal appearing edge and arsenical cancers. A disruption of the uniform Langerhans cell dendrites was also noticed. The Langerhans cell density in arsenical tumors did not correlate with the peritumoral infiltrates. The prominent infiltrated cells in the peritumoral area had T cell markers. The number of peritumoral T lymphocytes in squamous cell carcinoma was significantly less than that of Bowen's disease and basal cell carcinoma. Peritumoral mononuclear infiltrates in Bowen's disease and squamous cell carcinoma showed a higher helper/suppressor T cell ratio than that in basal cell carcinoma. This may be accounted for by a selective increased recruitment of helper T cells to the tumor infiltrates in Bowen's disease and squamous cell carcinoma.
Similar articles
-
Alterations of mitogenic responses of mononuclear cells by arsenic in arsenical skin cancers.J Dermatol. 1992 Nov;19(11):710-4. doi: 10.1111/j.1346-8138.1992.tb03765.x. J Dermatol. 1992. PMID: 1293158
-
Arsenical cancer of skin. Histologic study with special reference to Bowen's disease.Cancer. 1968 Feb;21(2):312-39. doi: 10.1002/1097-0142(196802)21:2<312::aid-cncr2820210222>3.0.co;2-k. Cancer. 1968. PMID: 4952508 No abstract available.
-
Quantitative and morphological changes of Langerhans cells in Bowen's disease from patients with chronic arsenicism.J Formos Med Assoc. 1991 Nov;90(11):1093-8. J Formos Med Assoc. 1991. PMID: 1687057
-
Immunological dysfunction in chronic arsenic exposure: From subclinical condition to skin cancer.J Dermatol. 2018 Nov;45(11):1271-1277. doi: 10.1111/1346-8138.14620. Epub 2018 Aug 25. J Dermatol. 2018. PMID: 30144155 Review.
-
Aberrant immune responses in arsenical skin cancers.Kaohsiung J Med Sci. 2011 Sep;27(9):396-401. doi: 10.1016/j.kjms.2011.05.007. Epub 2011 Jul 6. Kaohsiung J Med Sci. 2011. PMID: 21914527 Free PMC article. Review.
Cited by
-
Knowledge building insights on biomarkers of arsenic toxicity to keratinocytes and melanocytes.Biomark Insights. 2012;7:127-41. doi: 10.4137/BMI.S7799. Epub 2012 Oct 15. Biomark Insights. 2012. PMID: 23115478 Free PMC article.
-
Concentration-dependent cellular responses of arsenic in keratinocytes.Kaohsiung J Med Sci. 2011 Sep;27(9):390-5. doi: 10.1016/j.kjms.2011.05.006. Epub 2011 Aug 9. Kaohsiung J Med Sci. 2011. PMID: 21914526 Free PMC article. Review.
-
Proteomics-Based Identification of Differentially Abundant Proteins from Human Keratinocytes Exposed to Arsenic Trioxide.J Proteomics Bioinform. 2014 Jul;7(7):166-178. doi: 10.4172/jpb.1000317. J Proteomics Bioinform. 2014. PMID: 25419056 Free PMC article.
-
Integration of microRNAome, proteomics and metabolomics to analyze arsenic-induced malignant cell transformation.Oncotarget. 2017 Jun 27;8(53):90879-90896. doi: 10.18632/oncotarget.18741. eCollection 2017 Oct 31. Oncotarget. 2017. PMID: 29207610 Free PMC article.
-
Chromated copper arsenate-treated wood: a potential source of arsenic exposure and toxicity in dermatology.Int J Womens Dermatol. 2016 Mar 28;2(1):28-30. doi: 10.1016/j.ijwd.2016.01.002. eCollection 2016 Mar. Int J Womens Dermatol. 2016. PMID: 28491998 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Medical